Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Chieh-Sheng Lu Yi-Ying Wu |
| Publication date | January 14, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |